Pharmacogenetic characterization of indacaterol, a novel β(2)-adrenoceptor agonist

BACKGROUND AND PURPOSE: Indacaterol is a novel β(2)-adrenoceptor agonist in development for the treatment of chronic obstructive pulmonary disease. The aim of this study was to investigate the comparative pharmacology of indacaterol in recombinant cells expressing the common polymorphic variants of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sayers, I, Hawley, J, Stewart, CE, Billington, CK, Henry, A, Leighton-Davies, JR, Charlton, SJ, Hall, IP
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2009
Matèries:
Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2795231/
https://ncbi.nlm.nih.gov/pubmed/19422388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2009.00224.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars